Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.84 HKD | +0.64% |
|
+1.73% | -11.55% |
Jun. 12 | Sinopharm Group Co. Ltd. Approves Board Appointments | CI |
Jun. 10 | Sinopharm Unit to Acquire 21% Stake in Pacific Shuanglin Bio-pharmacy | MT |
Business description: Sinopharm Group Co. Ltd.
Number of employees: 108,217
Sales by Activity: Sinopharm Group Co. Ltd.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Pharmaceutical Distribution | 348B | 390B | 407B | 441B | 444B |
Medical Devices | 89.4B | 108B | 121B | 130B | 118B |
Retail Pharmacy | 24.16B | 29.06B | 32.98B | 35.69B | 35.98B |
Other Business | 7.65B | 9.82B | 10.21B | 10.39B | 9.11B |
Eliminations | -13.1B | -15.91B | -18.5B | -20.77B | -22.86B |
Geographical breakdown of sales: Sinopharm Group Co. Ltd.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
People's Republic of China (PRC) | 456B | 521B | 552B | 597B | 585B |
Executive Committee: Sinopharm Group Co. Ltd.
Manager | Title | Age | Since |
---|---|---|---|
Wan Yong Lian
PSD | President | 55 | 2024-08-26 |
Yi Jian Wu
SEC | Corporate Secretary | 55 | - |
Xiu Chang Jiang
DFI | Director of Finance/CFO | 61 | 2010-04-30 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 56 | 2011-02-28 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 60 | 2010-04-30 |
Composition of the Board of Directors: Sinopharm Group Co. Ltd.
Director | Title | Age | Since |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 53 | 2010-04-30 |
Zheng Dong Liu
BRD | Director/Board Member | 55 | 2014-09-20 |
De Yong Wen
BRD | Director/Board Member | 53 | 2017-08-31 |
Xiao Hui Guan
CHM | Chairman | 54 | - |
Rong Li Feng
BRD | Director/Board Member | 48 | 2020-06-10 |
Tak Lung Wu
BRD | Director/Board Member | 59 | 2020-09-17 |
Wei Feng Yu
BRD | Director/Board Member | 62 | 2020-09-17 |
Hai Qing Lu
BRD | Director/Board Member | 51 | 2020-09-17 |
Pei Yu Li
BRD | Director/Board Member | 62 | 2020-09-17 |
Sheng Hao Shi
BRD | Director/Board Member | 56 | 2023-06-14 |
Company details: Sinopharm Group Co. Ltd.
Sinopharm Group Co., Ltd.
Sinopharm Group Building No. 385, East Longhua Road
200023, Shanghai
+86 21 2305 2666
http://ir.sinopharmgroup.com.cn
Pharmaceuticals Wholesale
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.64% | +1.73% | -4.85% | -4.37% | 7.44B | ||
-0.69% | -1.35% | +23.36% | +115.81% | 89.39B | ||
-0.74% | -2.40% | +70.41% | +203.77% | 38.71B | ||
+0.35% | -4.98% | - | - | 21.59B | ||
+0.73% | -1.57% | +47.10% | -10.62% | 9.72B | ||
+1.60% | +5.97% | +0.32% | +2.76% | 8.71B | ||
-0.68% | -1.24% | +15.56% | +14.13% | 5.52B | ||
+0.93% | -1.80% | -14.32% | -5.59% | 5.21B | ||
-0.50% | +1.72% | +20.12% | +3.69% | 4.93B | ||
+0.38% | +2.69% | +12.66% | +20.35% | 3.7B | ||
Average | +0.26% | +0.67% | +18.93% | +37.77% | 19.49B | |
Weighted average by Cap. | -0.00% | -0.52% | +31.13% | +105.41% |
Sector

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1099 Stock
- Company Sinopharm Group Co. Ltd.
Select your edition
All financial news and data tailored to specific country editions